Codex DNA Price on November 22, 2021

DNAYDelisted Stock  USD 1.30  0.10  8.33%   
If you're considering investing in Codex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Codex DNA stands at 1.30, as last reported on the 28th of March, with the highest price reaching 1.31 and the lowest price hitting 1.20 during the day. We have found twenty-four technical indicators for Codex DNA, which you can use to evaluate the volatility of the firm. Please confirm Codex DNA's mean deviation of 3.48, and Risk Adjusted Performance of (0.03) to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Codex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
DNAY
Based on monthly moving average Codex DNA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Codex DNA by adding Codex DNA to a well-diversified portfolio.

Codex DNA Valuation on November 22, 2021

It is possible to determine the worth of Codex DNA on a given historical date. On November 22, 2021 Codex was worth 9.33 at the beginning of the trading date compared to the closed value of 9.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Codex DNA stock. Still, in general, we apply an absolute valuation method to find Codex DNA's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Codex DNA where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Codex DNA's related companies.
 Open High Low Close Volume
03/14/2022
  9.33    9.75    8.60    9.20    214,600  
  9.25    9.46    9.07    9.21    127,300  
Backtest Codex DNA  |  Codex DNA History  |  Codex DNA Valuation Next  
Open Value
9.33
9.2
Closing Value
9.33
Upside

Codex DNA Trading Date Momentum on November 22, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Codex DNA Fundamentals Correlations and Trends

By evaluating Codex DNA's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Codex DNA's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Codex financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Codex DNA Stock history

Codex DNA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Codex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Codex DNA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Codex DNA stock prices may prove useful in developing a viable investing in Codex DNA
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California. Codex Dna operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.

Codex DNA Stock Technical Analysis

Codex DNA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Codex DNA technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Codex DNA trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Codex DNA Period Price Range

Low
March 14, 2022
High

 9.33 

  

 9.20 

-0.13-1.39%

Codex DNA March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Codex DNA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Codex DNA shares will generate the highest return on investment. By undertsting and applying Codex DNA stock market strength indicators, traders can identify Codex DNA entry and exit signals to maximize returns

Codex DNA Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Codex DNA's price direction in advance. Along with the technical and fundamental analysis of Codex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Codex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Codex DNA information on this page should be used as a complementary analysis to other Codex DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Codex Stock

If you are still planning to invest in Codex DNA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Codex DNA's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets